Publication | Closed Access
A phase Ib/II study of neoadjuvant pembrolizumab (pembro) and chemotherapy for locally advanced urothelial cancer (UC)
35
Citations
0
References
2018
Year
UrologyGenitourinary CancerMedicineImmune Checkpoint InhibitorAdvanced Urothelial CancerNeoadjuvant PembrolizumabPhase Ib/ii StudyCancer TreatmentOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!